Netherlands· NL-01b85c75f6c4

Feminegi 3 mg/0,03 mg filmomhulde tabletten

A drospirenone and ethinylestradiol product containing drospirenon + ethinylestradiol, registered in Netherlands by Egis Pharmaceuticals Plc. The same ATC class is registered in 13 of our 19 countries.

ATC G03AA12

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about drospirenon + ethinylestradiolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Drospirenone and ethinylestradiol is registered in 13 of 19 countries.

Countries holding a registration under ATC G03AA12 (drospirenone and ethinylestradiol), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search drospirenone and ethinylestradiol products by name

Drospirenone and ethinylestradiol · ATC G03AA12

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: DROSPIRENON + ETHINYLESTRADIOL
Manufacturer: Egis Pharmaceuticals Plc
Country: Netherlands (NL)
ATC code: G03AA12
ATC class: Drospirenone and ethinylestradiol
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
113247

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

517 interactions on record for drospirenone and ethinylestradiol.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check drospirenone and ethinylestradiol against other medicines How interaction checks work

Drospirenone and ethinylestradiol · interactions on record

517 records

50 severe
386 moderate
49 minor

Most severe, free to view

Tranexamic acidB02AA02severe
HeminB06AB01severe
BosentanC02KX01severe
GriseofulvinD01AA08severe

32 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Drospirenone and ethinylestradiol in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All drospirenone and ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Aliane, Danselle 21
Belgium · Annaïs 20, Annaïs 30 Ceres Pharma
Bulgaria · Жанги, Крипинео
Cyprus · Yasmin, Yasminelle
Czechia · Abella, Cris
Germany · Aida, Drospifem 20
Denmark · Asubtela, Etindros 21
Estonia · Jangee, Madeleine
Spain · Aidra, Aidraelle
Finland · Diza, Midiana
France · Drospibel, Drospirenone/Ethinylestradiol
United Kingdom (Northern Ireland) · Dretine, Ellanite
Greece · Estrofix, Yasmin
Croatia · Crypineo, Rosanne
Hungary · Altforalle, Aranka
Ireland · Dretine, Dretinelle
Iceland · Asubtela, Yasmin
Italy · Calindir, Cris
Lithuania · Edrocont, Etindros
Luxembourg · Annaïs 20 Ceres Pharma, Annaïs 30 Ceres Pharma
Latvia · Etindros, Midiana
Malta · Edrocont, Freedonel
Norway · Calima, Diza
Poland · Asubtela, Axia
Portugal · Aranka, Arankelle
Romania · Yasmin
Sweden · Diza, Maitalon
Slovenia · Crypineo, Daylla
Slovakia · Daylla, Emie

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/db724890-012e-465c-8e22-15dfd9ac6100
GET /v1/drugs/db724890-012e-465c-8e22-15dfd9ac6100?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h113247_smpc_en.pdf",
  "strength": null,
  "atc_label": "Drospirenone And Ethinylestradiol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg113247",
  "excipients": [
    "CROSPOVIDON (E 1202)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "POLYSORBAAT 80 (E 433)",
    "POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
    "POVIDON K 30 (E 1201)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "DROSPIRENON",
    "ETHINYLESTRADIOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h113247_piluk.pdf",
  "authorised_at": "2014/03/26",
  "procedure_number": "NL/H/2889/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "113247",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about drospirenone and ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console